| Authors: |
Burris HA 3rd; Sarah Cannon Research Institute, Tennessee Oncology, Nashville, TN, USA. Electronic address: howard.burris@sarahcannon.com., Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Vogel A; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany., Lee MA; Division of Medical Oncology, Department of Internal Medicine, Seoul St Mary's Hospital, Seoul, South Korea; College of Medicine, Catholic University of Korea, Seoul, South Korea., Takahashi H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan., Breder V; Department of Chemotherapy, N N Blokhin Russian Cancer Research Center, Moscow, Russia., Blanc JF; Department of Hepato-gastroenterology and Digestive Oncology, Hôpital Haut-Lévêque, Bordeaux, France., Li J; Department of Oncology, First Affiliated Hospital of Nanchang University, Nanchang, China., Bachini M; Cholangiocarcinoma Foundation, Herriman, UT, USA., Żotkiewicz M; AstraZeneca, Warsaw, Poland., Abraham J; Patient Centered Solutions, New York, NY, USA., Patel N; AstraZeneca, Gaithersburg, MD, USA., Wang J; AstraZeneca, Gaithersburg, MD, USA., Ali M; AstraZeneca, Gaithersburg, MD, USA., Rokutanda N; AstraZeneca, Gaithersburg, MD, USA., Cohen G; AstraZeneca, Gaithersburg, MD, USA., Oh DY; Division of Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. |
